Download PDF
kleintier konkret 2019; 22(01): 4-12
DOI: 10.1055/a-0818-1009
Hund
Innere Medizin
Georg Thieme Verlag KG Stuttgart · New York

Insulinbehandlung beim Hund – Was gilt es zu beachten?

Katarina Hazuchova
Further Information

Publication History

Publication Date:
27 February 2019 (online)

Also available at
    Permissions and Reprints All articles of this category

Das Management des Diabetes mellitus ist anspruchsvoll, behandelte Hunde können jedoch eine gute Lebensqualität haben. Die Insulintherapie ist bei diabetischen Hunden absolut unerlässlich. Eine adäquate Ernährung, regelmäßige Bewegung und Behandlung der Begleiterkrankungen ist wichtig, um einen guten Therapieerfolg zu erzielen.
 

  • Literatur

  • 1 Gilor C, Niessen SJ, Furrow E. et al. Whatʼs in a Name? Classification of diabetes mellitus in veterinary medicine and why it matters. J Vet Intern Med 2016; 30 (04) 927-940
    CrossrefPubMedGoogle Scholar
  • 2 Gostelow R, Forcada Y, Graves T. et al. Systematic review of feline diabetic remission: separating fact from opinion. Vet J 2014; 202 (02) 208-221
    CrossrefPubMedGoogle Scholar
  • 3 Catchpole B, Adams JP, Holder AL. et al. Genetics of canine diabetes mellitus: Are the diabetes susceptibility genes identified in humans involved in breed susceptibility to diabetes mellitus in dogs?. Vet J 2013; 195 (02) 139-147
    CrossrefPubMedGoogle Scholar
  • 4 Davison LJ. Diabetes mellitus and pancreatitis – cause or effect?. J Small Anim Pract 2015; 56 (01) 50-59
    CrossrefPubMedGoogle Scholar
  • 5 Behrend E, Holford A, Lathan P. et al. 2018 AAHA Diabetes Management Guidelines for Dogs and Cats. J Am Anim Hosp Assoc 2018; 54 (01) 1-21
    CrossrefPubMedGoogle Scholar
  • 6 Fracassi F, Linari G, Del Baldo F. et al. Comparison of lente insulin and NPH insulin therapy for the treatment of newly diagnosed diabetic dogs: a randomised study. Vet Rec 2018; 183 (08) 262
    CrossrefPubMedGoogle Scholar
  • 7 Fleeman LM, Rand JS, Morton JM. Pharmacokinetics and pharmacodynamics of porcine insulin zinc suspension in eight diabetic dogs. Vet Rec 2009; 164 (08) 232-237
    CrossrefPubMedGoogle Scholar
  • 8 Clark M, Thomaseth K, Heit M. et al. Pharmacokinetics and pharmacodynamics of protamine zinc recombinant human insulin in healthy dogs. J Vet Pharmacol Ther 2012; 35 (04) 342-350
    CrossrefPubMedGoogle Scholar
  • 9 Sako T, Mori A, Lee P. et al. Time-action profiles of insulin detemir in normal and diabetic dogs. Res Vet Sci 2011; 90 (03) 396-403
    CrossrefPubMedGoogle Scholar
  • 10 Mori A, Sako T, Lee P. et al. Comparison of time-action profiles of insulin glargine and NPH insulin in normal and diabetic dogs. Vet Res Commun 2008; 32 (07) 563-573
    CrossrefPubMedGoogle Scholar
  • 11 Sparkes AH, Cannon M, Church D. et al. ISFM consensus guidelines on the practical management of diabetes mellitus in cats. J Feline Med Surg 2015; 17 (03) 235-250
    CrossrefPubMedGoogle Scholar
  • 12 Fracassi F, Boretti FS, Sieber-Ruckstuhl NS. et al. Use of insulin glargine in dogs with diabetes mellitus. Vet Rec 2012; 170 (02) 52
    CrossrefPubMedGoogle Scholar
  • 13 Fracassi F, Corradini S, Hafner M. et al. Detemir insulin for the treatment of diabetes mellitus in dogs. J Am Vet Med Assoc 2015; 247 (01) 73-78
    CrossrefPubMedGoogle Scholar
  • 14 Maggiore AD, Nelson RW, Dennis J. et al. Efficacy of protamine zinc recombinant human insulin for controlling hyperglycemia in dogs with diabetes mellitus. J Vet Intern Med 2012; 26 (01) 109-115
    CrossrefPubMedGoogle Scholar
  • 15 Hess RS, Ward CR. Effect of insulin dosage on glycemic response in dogs with diabetes mellitus: 221 cases (1993–1998). J Am Vet Med Assoc 2000; 216 (02) 217-221
    CrossrefPubMedGoogle Scholar
  • 16 Monroe WE, Laxton D, Fallin EA. et al. Efficacy and safety of a purified porcine insulin zinc suspension for managing diabetes mellitus in dogs. J Vet Intern Med 2005; 19 (05) 675-682
    CrossrefPubMedGoogle Scholar
  • 17 Gostelow R, Hazuchova K, Scudder C. et al. Prospective evaluation of a protocol for transitioning porcine lente insulin-treated diabetic cats to human recombinant protamine zinc insulin. J Feline Med Surg 2018; 20 (02) 114-121
    CrossrefPubMedGoogle Scholar
  • 18 Hazuchova K, Gostelow R, Scudder C. et al. Acceptance of home blood glucose monitoring by owners of recently diagnosed diabetic cats and impact on quality of life changes in cat and owner. J Feline Med Surg 2018; 20 (08) 711-720
    CrossrefPubMedGoogle Scholar
  • 19 Corradini S, Pilosio B, Dondi F. et al. Accuracy of a flash glucose monitoring system in diabetic dogs. J Vet Intern Med 2016; 30 (04) 983-988
    CrossrefPubMedGoogle Scholar
  • 20 Fleeman LM, Rand JS. Evaluation of day-to-day variability of serial blood glucose concentration curves in diabetic dogs. J Am Vet Med Assoc 2003; 222 (03) 317-321
    CrossrefPubMedGoogle Scholar
  • 21 Davison LJ, Walding B, Herrtage ME. et al. Anti-insulin antibodies in diabetic dogs before and after treatment with different insulin preparations. J Vet Intern Med 2008; 22 (06) 1317-1325
    CrossrefPubMedGoogle Scholar